On July 24th, the global medical industry announced that it had completed the B round of financing, with a financing amount of 700 million yuan. This round of financing was led by Zhongjin Capital Operation Co., Ltd., a wholly-owned subsidiary of China International Capital Corporation. The CLP Health Industry Fund and Shanghai Jinpu Jianfu Equity Investment Management Co., Ltd. were the first to be state-owned capital. Tumor radiotherapy platform-type enterprises inject capital.
The global medical disclosure revealed that this round of financing will be mainly used to build a global intelligent radiotherapy demonstration hospital with the core of intelligent radiotherapy system construction and operation services, strengthen information construction, open up all links of production, education and research to improve the intelligence and homogenization of cancer treatment. Level. In addition, the global medical care will deepen the integration of radiotherapy resources, build a precision radiotherapy medical joint platform, form a new service model for tumor radiotherapy that can be replicated and promoted, and empower the radiotherapy units at all levels.
The data show that the number of cancer patients in China ranks first in the world, and China accounts for about 36% of new cancer patients each year, and 70% of tumors require radiation therapy. However, at the grassroots level in China, due to lack of equipment or lack of quality control, it is difficult for patients to obtain accurate radiation therapy in the local area, and health is seriously threatened.
By integrating the resources of all parties and building a platform for precision radiotherapy, the global medical system is committed to enabling grassroots patients to enjoy the diagnosis and treatment services of high-end medical experts at county-level medical institutions, reducing the burden of medical treatment for patients, and achieving “a big illness without leaving the countyâ€. aims.
In 2017, the global medical success application for the national key research and development plan "based on the 'Internet +' tumor radiotherapy new service model - 'precision cloud radiotherapy' system development and application research", through the participation of a number of units of production, education and research, improve the overall radiotherapy The solution is to create a new service model for tumor radiotherapy. It is reported that the global precision cloud radiotherapy collaboration system for Internet teleconsultation and multidisciplinary consultation (MDT) has been used in the First People's Hospital of Yinchuan City. Chongqing also relies on global technology to create a “one network and one chain†cancer prevention and control system. A complete medical service chain for regional collaboration.
According to the data, the global medical care has formed a strategic partnership with 526 medical institutions across the country, and provided a total solution for 72 hospitals, forming a number of top hospitals and primary radiotherapy units connected to the US MD Anderson Cancer Center, the Chinese Academy of Medical Sciences Cancer Hospital, and so on. Tumor intelligent radiotherapy medical platform.
In terms of big data and artificial intelligence, the global medical and the CLP Health Industry Fund jointly promote the collection, collation and application of tumor big data. At the same time, the company has invested in two artificial intelligence companies, relying on big data foundation and machine learning technology, and together with Beijing University of Aeronautics and Astronautics, the United States MD Anderson Cancer Center and other institutions to develop artificial intelligence radiotherapy products, effectively improve the quality and overall efficiency of radiotherapy.
Kang Shigong, co-founder and vice president of Global Medical, said: "Global Oncology One Lab, which was established by Global Medical and MD Anderson Cancer Center in the United States, has been deeply involved in the field of AI+ radiotherapy since the launch of mdaccAutoPlan in 2012." At this stage, global medical care is in AI. Research and development of multiple radiotherapy techniques such as intelligent delineation, AI plan evaluation, and AI quality control prediction.
In response to the shortage of tumors in many domestic medical information manufacturers and the small selection of informatization products in the department, the global medical cooperation with many manufacturers in the industry, the informationization of radiotherapy and oncology departments and the entire hospital The informatization construction is seamlessly integrated, and on the other hand, the more complex system of oncology is combined with the huge system of the hospital.
In the future, the global medical care will continue to improve the quality control platform for cancer radiotherapy, strengthen the innovative exploration of the service system, and empower the primary tumor radiotherapy unit. In this process, the global medical care will also focus on exploring the cancer diagnosis and treatment business and service ecosystem, actively connecting with high-quality medical resources in the industry, and continuously collaborating and integrating resources with new technologies, new products and services in the industry.
Alcohol Fructose Syrup,High Fructose Corn Syrup Juice,Fructose In Agave Syrup,Glucose Fructose Syrup Dangers
JILIN COFCO BIO-CHEM AND BIO-ENERGY MARKETING CO., LTD , https://www.cofco-biotech.com